Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wissel

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Wiener Klinische Wochenschrift|December 10, 1999
[Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group]J Wissel, J Müller, F Heinen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2000
The DYT1 GAG deletion is infrequent in sporadic and familial writer' s crampC Kamm, M Naumann, J Mueller, et al.
Journal of Neurology|March 3, 2004
Consensus statement: botulinum toxin in myofascial [corrected] painP Reilich, K Fheodoroff, U Kern, et al.
European Journal of Nuclear Medicine|September 28, 2000
Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPECT study using 123I-beta-CIT and 123I-IBZME Donnemiller, C Brenneis, J Wissel, et al.
Experimental Neurology|August 1, 1995
The "campus syndrome" in pigs: neurological, neurophysiological, and neuropharmacological characterization of a new genetic animal model of high-frequency tremorA Richter, J Wissel, B Harlizius, et al.
Neuropediatrics|February 7, 1998
Interventional neuropediatrics: treatment of dystonic and spastic muscular hyperactivity with botulinum toxin AF Heinen, J Wissel, A Philipsen, et al.
Neurorehabilitation and Neural Repair|February 21, 2009
Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticityD Bensmail, A B Ward, J Wissel, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 20, 2004
Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrumentJ Müller, J Wissel, G Kemmler, et al.
Neuroscience Letters|June 17, 1998
Modulation of upper extremity motoneurone excitability following noxious finger tip stimulation in man: a study with transcranial magnetic stimulationM Kofler, F X Glocker, A A Leis, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 30, 2001
Modulation of upper extremity motor evoked potentials by cutaneous afferents in humansM Kofler, P Fuhr, A A Leis, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Wiener Klinische Wochenschrift|December 10, 1999
[Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group]J Wissel, J Müller, F Heinen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2000
The DYT1 GAG deletion is infrequent in sporadic and familial writer' s crampC Kamm, M Naumann, J Mueller, et al.
Journal of Neurology|March 3, 2004
Consensus statement: botulinum toxin in myofascial [corrected] painP Reilich, K Fheodoroff, U Kern, et al.
European Journal of Nuclear Medicine|September 28, 2000
Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPECT study using 123I-beta-CIT and 123I-IBZME Donnemiller, C Brenneis, J Wissel, et al.
Experimental Neurology|August 1, 1995
The "campus syndrome" in pigs: neurological, neurophysiological, and neuropharmacological characterization of a new genetic animal model of high-frequency tremorA Richter, J Wissel, B Harlizius, et al.
Neuropediatrics|February 7, 1998
Interventional neuropediatrics: treatment of dystonic and spastic muscular hyperactivity with botulinum toxin AF Heinen, J Wissel, A Philipsen, et al.
Neurorehabilitation and Neural Repair|February 21, 2009
Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticityD Bensmail, A B Ward, J Wissel, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 20, 2004
Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrumentJ Müller, J Wissel, G Kemmler, et al.
Neuroscience Letters|June 17, 1998
Modulation of upper extremity motoneurone excitability following noxious finger tip stimulation in man: a study with transcranial magnetic stimulationM Kofler, F X Glocker, A A Leis, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 30, 2001
Modulation of upper extremity motor evoked potentials by cutaneous afferents in humansM Kofler, P Fuhr, A A Leis, et al.
Pageof 7